Barr Pharmaceuticals will resubmit its application for nonprescription sales of the morning-after pill, possibly putting an end to three years of federal hand-wringing over the sexual proclivities of 17-year-olds. Barr has compromised, agreeing to limit the over-the-counter version to women 18 and over. (Pharmacies will have to enforce the rule.) Given that there is no credible medical reason for the restriction, the FDA appears to be overtly caving to political pressure from conservatives. But at the same time, it's a pretty hollow victory for the forces of abstinence. What 16-year-old is going to incur the expense of a doctor visit when she can ask an older friend or sister (or friend's sister) to walk into a pharmacy for her? Are bands of kids going to hang out outside CVS, asking strangers to grab some contraception for them? The prescription version won't even be worth stocking.
"By phasing out these courses, all students will have access to an inclusive model of education."
Plus: Georgia's voting roll purge draws media hype, Florida's drug law hypocrisy, and more...
Biden's Nominee to Head the ATF, Who Wants Congress to Ban 'Assault Weapons,' Says He Can't Define Them
David Chipman's obfuscation, like the president's vagueness, is aimed at concealing the illogic of targeting firearms based on their "military-style" appearance.
Warren Lent is suing the California Coastal Commission, arguing that its power to unilaterally hand down massive fines with minimal process is unconstitutional.